Patricia Matthews-Juarez

Nov 30, 2023 | usnews.com | Joneigh Khaldun |Patricia Matthews-Juarez

In the United States’ ongoing effort to reduce health care disparities, community health workers are an underutilized and valuable resource. As health care companies, nonprofit organizations and government agencies work to expand access to care, it is important to understand how these professionals can help our communities. Community health workers are front-line public health workers who are trusted members of or deeply understand the communities they serve.

Jun 7, 2023 | mdpi.com | Donald J. Alcendor |Patricia Matthews-Juarez |Neely Williams |Derek Wilus

2. MethodsSurveys: Exactly 1482 surveys were administered to participants that were 18 years and older and were among predominantly medically underserved minority communities in Tennessee at pop-up vaccine events, cultural gatherings, churches and other places of worship, pediatric clinics, metro parks, back-to-school events, community-based organization events, health department events, large and small businesses, festivals, nursing homes, and assisted-living facilities.

Jun 5, 2023 | journals.plos.org | Mohammad Tabatabai |Patricia Matthews-Juarez |Donald J. Alcendor |Nader Bahri

Analysis of survival by incomeFig 1F shows the higher the income, the higher the survival probability. Only 0.3% of patients had income less than $40,000. The MST for people earning less than $40,000 was 118 months. For those 8.4% of patients who were making 40,000–55,000 dollars a year, the MST was 131 months. Patients in the income range of 55,000–75,000 constituted 47.7% of patients with the MST of 146 months. For those 43.7% of the patients making more than $75,000, the MST was 158 months.

Apr 27, 2023 | mdpi.com | Donald J. Alcendor |Patricia Matthews-Juarez |Duane L Smoot |Alexis Edwards

Abstract:The COVID-19 Omicron variant and its subvariants are now the dominant variants circulating in the US. Therefore, the original COVID-19 vaccine cannot offer full protection. Instead, vaccines that target the spike proteins of the Omicron variants are warranted. Hence, the FDA recommended the development of a bivalent booster. Unfortunately, despite the safety and immunogenicity of the Omicron bivalent boosters from Pfizer and Moderna, uptake in the US has been poor.